By J. Richard Smith, Giuseppe Del Priore, Robert L. Coleman, John M. Monaghan, John Curtin
Absolutely up-to-date and revised, the second one variation of An Atlas of Gynecologic Oncology offers an entire description of the investigative and surgeries performed via the gynecologic oncologist. Key positive factors of this crucial textual content comprise:
Read or Download Atlas of Gynecologic Oncology PDF
Best obstetrics & gynecology books
Das Klinikmanual gibt zuverl? ssig, schnell und pr? zise Antworten auf akute Fragen. Die Autoren haben die relevanten Themen der Gyn? kologie und Geburtshilfe kompakt und ? bersichtlich aufbereitet und nach Anamnese, Klinik, Diagnostik, Sofortma? nahmen, Behandlung, therapeutischem Vorgehen und Beratung gegliedert.
Gynecology and Obstetrics summarizes prognosis and administration of universal problems that take place in ladies. this article stories authorized remedy directions for either inpatients and outpatients. 149 pages.
The latest simple technological know-how identify within the High-Yield™ sequence, this glorious path and board assessment publication extracts in basic terms an important information about pathology. provided in a concise, uncluttered model, High-Yield™ Pathology is representation and desk extensive, with thousands of assessment questions.
Having merely emerged long ago few many years, Feminist Philosophy is quickly constructing its personal thrust in parts of specific value to feminism_and girls extra generally_while additionally reevaluating and reshaping so much different fields of philosophy, from ethics to good judgment and Marxism to environmentalism. It attracts not just on feminist philosophers yet criticizes, approves, or appropriates the paintings of the top philosophers of all occasions.
- Clinical Obstetrics and Gynaecology
- Managing Cancer during Pregnancy
- Berek & Novak's Gynecology (Berek and Novak's Gynecology)
- Handbook of Obstetric Medicine
Additional resources for Atlas of Gynecologic Oncology
Html Page 30 growth of tumor cells and metastasis. It is also likely that cytokines produced by tumors will modulate immune responses that favor tumor progression (Nash et al. 1999). It is clear that cytokines do not fulfill the classic criteria for tumor markers. They are invariably produced by non-malignant tissue, may be elevated in a number of pathological conditions, are not specific for one cell type and in the malignant scenario are often produced by the surrounding tissue in response to the tumor rather then by the tumor itself.
In contrast to Cytokeratins themselves, fragments of Cytokeratins are soluble in the serum and therefore can be detected and measured with the aid of monoclonal antibodies. Those currently being studied as tumor markers in ovarian cancer are tissue polypeptide-specific antigen (TPS), a proliferation marker recognized by a monoclonal antibody raised against cytokeratin 18 and CYFRA 21–1, a soluble serum fragment of cytokeratin 19. Elevated TPS levels may add to the diagnostic value of serum CA125 in ovarian cancer (Shabana and Onsrud 1994, Sliutz et al.
While authors agree that raised levels reflect advanced stage and portend a poor prognosis, there is controversy as to whether this adds any information to that gained by history, physical examination, preoperative imaging and surgery (Cherchi et al. 1999, Schneider et al. 1999). CA125 rises progressively with worsening grade. It was suggested that it may have a role in posttreatment surveillance of patients with early-stage endometrial cancer. However, levels can be falsely elevated in the presence of severe radiation injury (Rose et al.
Atlas of Gynecologic Oncology by J. Richard Smith, Giuseppe Del Priore, Robert L. Coleman, John M. Monaghan, John Curtin